Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Fulvestrant (ATC-Code: L02BA03)

World Biggest Tenders Source

This tender with title Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Fulvestrant (ATC-Code: L02BA03) has been published on Bidding Source portal dated 16 Jul 2019 for the country of Germany. It has been categorized on Endocrine therapy medicinal products. For similar tenders you can see tenders mentioned below of this page.

General Information

Germany

Tender Title :

Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Fulvestrant (ATC-Code: L02BA03)

Tender Type :

Contract notice

Reference No. :

2019/S 134-329035

Country :

Germany

Province/City :

Germany-Hanover

Publish Date :

16 Jul 2019

Closing Date :

27 Jun 2021

Notice Language :

English

Tender Categories (CPVs) :

Endocrine therapy medicinal products

Full Tender Details :

For viewing full details of tenders, you should Log in to your account. If not registered yet, Please Register Now

Or Request a call back now and one of our representatives will contact you. Contact us

Similar Tenders

Germany - Conclusion of a non-exclusive discount agreement according to Section 130a Paragraph 8 SGB V for medicinal products with the active ingredient fulvestrant (ATC code: L02BA03). -- Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Fulvestrant (ATC-Code: L02BA03). Germany Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Leuprorelin (ATC-Code: L02AE02) -- Endocrine therapy medicinal products Germany Endocrine therapy medicinal products - Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Leuprorelin (ATC-Code: L02AE02) Germany Germany-Hanover: Endocrine therapy medicinal products Germany Endocrine therapy medicinal products – Apalutamid - 685406 Czech Republic Endocrine therapy medicinal products – Supplies of medicines – Medicinal substance goserelin – ATC L02AE03 - 671820 Czech Republic PROCUREMENT OF DRUGS USED IN MANAGEMENT OF ENDOCRINE DISORDERS (ANNUAL REQUIREMENTS) MHPQ/PHARM/2024-2025/Q48 OIB - IFB/2024/1926 Mauritius Awarded - SUPPLY OF ANTIBIOTICS MACROLIDES AND ENDOCRINE ADRENALS DRUGS - Trinidad and Tobago -- Contract Value: TTD 400300.00 Trinidad And Tobago Endocrine therapy medicinal products – Endocrine therapy Czech Republic Offer for the supply of Degarelix Formulations - No. Dir. 81/2024 - OAU - Αρ. Διαγ. 81/2024 - ΟΑΥ Cyprus

Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Fulvestrant (ATC-Code: L02BA03)

General Information

Germany

Similar Tenders

Endocrine therapy medicinal products Tenders

Germany Tenders

Europe Tenders

Tenders

info@biddingsource.com